ES2218796T3 - Uso de un compuesto peptidico para el tratamiento del lupus erimatoso sistemico. - Google Patents
Uso de un compuesto peptidico para el tratamiento del lupus erimatoso sistemico.Info
- Publication number
- ES2218796T3 ES2218796T3 ES98830310T ES98830310T ES2218796T3 ES 2218796 T3 ES2218796 T3 ES 2218796T3 ES 98830310 T ES98830310 T ES 98830310T ES 98830310 T ES98830310 T ES 98830310T ES 2218796 T3 ES2218796 T3 ES 2218796T3
- Authority
- ES
- Spain
- Prior art keywords
- treatment
- systemic
- erimatus
- lupus
- peptidic compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
SE PRESENTA EL USO DE UN COMPUESTO PEPTIDICO DE LA FORMULA (I): (H 2 -N-X 1 -THR-X 2 -CO) N -R EN LA QUE X 1 , X 2 , N Y R TIENEN LOS SIGNIFICADOS RELACIONADOS EN LA DESCRIPCION PARA LA PREPARACION DE UNA COMPOSICION FARMACEUTICA UTIL EN EL TRATAMIENTO DEL LUPUS ERITHEMATOSUS SISTEMICO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98830310A EP0958829B1 (en) | 1998-05-21 | 1998-05-21 | Use of a peptide compound in the treatment of systemic lupus erythematosus |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2218796T3 true ES2218796T3 (es) | 2004-11-16 |
Family
ID=8236657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES98830310T Expired - Lifetime ES2218796T3 (es) | 1998-05-21 | 1998-05-21 | Uso de un compuesto peptidico para el tratamiento del lupus erimatoso sistemico. |
Country Status (7)
Country | Link |
---|---|
US (1) | US6303577B1 (es) |
EP (1) | EP0958829B1 (es) |
JP (1) | JP2000053580A (es) |
AT (1) | ATE267018T1 (es) |
CA (1) | CA2270687A1 (es) |
DE (1) | DE69823981T2 (es) |
ES (1) | ES2218796T3 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100719202B1 (ko) | 1998-10-23 | 2007-05-16 | 키린-암젠 인코포레이티드 | MPl 수용체에 결합하는 화합물 및 이를 함유하는 제약학적 조성물 |
US7488590B2 (en) | 1998-10-23 | 2009-02-10 | Amgen Inc. | Modified peptides as therapeutic agents |
US6916904B2 (en) | 2002-04-24 | 2005-07-12 | Zolaris Biosciences, Llc | Inhibition of immune complex formation |
US7442778B2 (en) | 2004-09-24 | 2008-10-28 | Amgen Inc. | Modified Fc molecules |
US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
TW200827367A (en) | 2006-10-26 | 2008-07-01 | Kyowa Hakko Kogyo Kk | A therapeutic agent for irritable bowel syndrome |
EP3134732A2 (en) * | 2014-04-24 | 2017-03-01 | Alnylam Pharmaceuticals, Inc. | Methods and compositions for detecting anti-drug antibodies |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7525796A (en) * | 1995-10-30 | 1997-05-22 | Merck & Co., Inc. | Novel inhibitors of peptide binding to mhc class ii proteins |
-
1998
- 1998-05-21 ES ES98830310T patent/ES2218796T3/es not_active Expired - Lifetime
- 1998-05-21 AT AT98830310T patent/ATE267018T1/de not_active IP Right Cessation
- 1998-05-21 DE DE69823981T patent/DE69823981T2/de not_active Expired - Fee Related
- 1998-05-21 EP EP98830310A patent/EP0958829B1/en not_active Expired - Lifetime
-
1999
- 1999-05-04 CA CA002270687A patent/CA2270687A1/en not_active Abandoned
- 1999-05-04 US US09/304,052 patent/US6303577B1/en not_active Expired - Fee Related
- 1999-05-21 JP JP11141795A patent/JP2000053580A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0958829B1 (en) | 2004-05-19 |
US6303577B1 (en) | 2001-10-16 |
CA2270687A1 (en) | 1999-11-21 |
DE69823981D1 (de) | 2004-06-24 |
JP2000053580A (ja) | 2000-02-22 |
ATE267018T1 (de) | 2004-06-15 |
DE69823981T2 (de) | 2005-05-25 |
EP0958829A1 (en) | 1999-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY34152A (es) | ?oxazolidinonas substituidas y su uso?. | |
ES2524006T3 (es) | Inhibición del crecimiento celular | |
DE60230340D1 (de) | N-Ä4-(4-Amino-2-ethyl-1H-imidazoÄ4,5-cÜchinolin-1-yl)butylÜmethanesulfonamide, diese enthaltende pharmazeutische Zusammensetzung und deren Verwendung | |
BR0111520A (pt) | Tiazina oxazolidinona usada como agente antimicrobiano | |
EA200100773A1 (ru) | Замещенные 1-гетероциклические диариламины | |
PT1231918E (pt) | Nova composicao e uso | |
DE69725825D1 (de) | 5-HT1F-Agonisten | |
BR9909329A (pt) | Método para estabilizar composições farmacêuticas pelo uso especial de um antioxidante | |
RU2001127848A (ru) | Гетероциклические ароматические соединения, усиливающие секрецию гормона роста | |
TR199902655A2 (xx) | K�k�rt-fonksiyonel poliorganosiloksanlar | |
TR200001012T2 (tr) | Yeni ariloksi-alkil-dialkilaminler. | |
AR016981A2 (es) | Polipeptidos sinteticos | |
IL173929A0 (en) | Analogues of kahalalide f and pharmaceutical compositions containing the same | |
ATE240303T1 (de) | 1,2,4-triazol-3-thion verbindungen | |
ES2218796T3 (es) | Uso de un compuesto peptidico para el tratamiento del lupus erimatoso sistemico. | |
BR0004860B1 (pt) | dispositivo para o condicionamento e a distribuição de uma composição e uso do dispositivo. | |
BG105539A (en) | Eletriptan hydrobromide monohydrate | |
MX9707974A (es) | Derivados de 10, 13, 15-trioxatriciclo [9.2.1.1 9.6]-pentadecanona, procedimientos para su preparacion y medicamentos que contienen estos compuestos. | |
BR0010317A (pt) | Bandeja de armazenagem para refrigerador | |
BR9713176A (pt) | Benzotiofenos amorfos,métodos de preparação e métodos de uso | |
DK1073447T3 (da) | N1-modificerede glycopeptider | |
BR0112600A (pt) | Compostos calcilìticos | |
EA200400670A1 (ru) | Фармацевтические композиции, содержащие 3,4-пропинопергидропурины, и их применение для блокирования нейронной передачи | |
DE69725459D1 (de) | Substituierte 1,2,3,4-tetrahydro-2-dibenzofuranamine und 2-aminocyclohepta(b)benzofurane | |
EP1059089A4 (en) | DRUGS FOR PREVENTING / TREATING INFLAMMATORY BOWEL DISEASE |